sees fy year-five sales $num-one billion to $num-two billion.
qtr-two sales $num-one million versus refinitiv ibes estimate of $496.1 million.
raising full-year year-five adjusted-diluted earnings per share guidance to a new range of between $num-one and $num-two.
west pharmaceutical services - net sales guidance includes estimated full-year headwind of $num-one million for year-five based on current foreign exchange rates.